Atherosclerosis develops over decades, silently, and it is driven by particles depositing into artery walls. A standard lipid panel measures how much cholesterol those particles are carrying. ApoB counts the particles themselves — and Lp(a) identifies an inherited risk that most people go their whole lives without ever having measured.
Reviewed by Dr. David Oliak, board-certified surgeon
Updated August 2026
Atherosclerosis is a particle problem. Cholesterol does not float freely in blood — it is carried inside lipoprotein particles, and disease begins when those particles cross into the artery wall and lodge there.
The more particles there are, the more often that happens. Particle number is therefore closer to the mechanism than the quantity of cholesterol being transported.
This is the distinction the standard lipid panel does not make. LDL cholesterol measures the cargo. It is a reasonable proxy for the number of vehicles, and most of the time it is a good one — but a proxy is what it is.
Every atherogenic particle — LDL, VLDL, IDL, and Lp(a) — carries exactly one molecule of ApoB. One particle, one ApoB.
That makes ApoB a direct count of how many particles are circulating and available to deposit. Not an estimate of it.
Where LDL cholesterol and ApoB agree, either will do. The value of measuring ApoB is that it tells you when they disagree — and it identifies the people for whom the standard panel is quietly misleading.
The mismatch has a name — discordance — and it is not random. It clusters.
When triglycerides are high, LDL particles tend to become smaller and denser. Smaller particles carry less cholesterol each, so it takes more of them to carry the same total. LDL cholesterol reads normal while particle number is elevated, because the cargo is spread across more vehicles.
The people this describes are the people with insulin resistance, raised triglycerides, low HDL, and weight around the middle. In other words: the group at highest metabolic risk is the group whose lipid panel most often looks fine.
That is the strongest single argument for measuring ApoB, and it is why this page and our fasting insulin page describe the same population from two directions.
Lp(a) is an LDL-like particle with an extra protein attached. It raises cardiovascular risk independently of everything else on a lipid panel, and it appears to do so through more than one mechanism.
Three things make it unusual.
It is largely inherited. Your level is set mostly by genetics rather than by diet, weight, or exercise.
It is stable. It does not move much across a lifetime, which means one measurement answers the question permanently.
It is rarely measured. A substantial minority of people have an elevated Lp(a), and most of them do not know, because it has never been on a panel they were given.
Because it is largely fixed, knowing it does not change what you can do about Lp(a) itself. What it changes is how seriously everything else gets treated — because a person carrying an inherited risk they cannot modify has more reason to address the risks they can.
Lp(a) is the marker we most often find that nobody has ever measured. It is inherited, it barely changes, and it needs testing exactly once — and yet people routinely reach sixty without knowing theirs.
Where it comes back high, it does not change what we can do about Lp(a) directly. It changes how hard we work on everything that is modifiable, and how early. A one-time test that reshapes decades of decisions is not a difficult call.
— Dr. David Oliak, board-certified physician and surgeon
Neither test is new, difficult, or costly. Both are widely available.
Routine lipid screening was built around total cholesterol, LDL, HDL and triglycerides, and those remain the markers most guidelines and most risk calculators are constructed from. Screening protocols change slowly, and for good reason — but the consequence is that the more precise measure and the inherited one both sit outside the standard set.
Cardiology has been moving toward both for some years. A comprehensive panel measures them now.
ApoB responds to the same things LDL does, and to the same things insulin resistance responds to: reducing refined carbohydrate, weight loss where it applies, exercise, and medication where the overall picture warrants it. Improving insulin resistance often improves the particle picture at the same time, which is one reason the two are read together.
Lp(a) is different. It does not respond meaningfully to diet or exercise. Its value is in what it tells you about everything else — a high Lp(a) shifts the threshold for treating blood pressure, ApoB, and metabolic risk more assertively, and earlier. It is also worth knowing for family: because it is inherited, an elevated result is relevant to your children and siblings.
Neither number is read alone. They sit alongside blood pressure, insulin, inflammatory markers, family history and everything else, and the plan comes from the whole picture rather than from one value.
Let's begin
ApoB, Lp(a) and a full lipid panel are part of the comprehensive panel, read alongside your metabolic and inflammatory markers and interpreted with you in an unhurried hour. In Brea. To speak with us first, call 714-671-2005.
What a comprehensive blood panel measures
Fasting insulin: the marker most panels skip
"Normal" versus optimal
The genetic blueprint
A protein carried by every particle capable of depositing cholesterol into an artery wall — one molecule per particle. Measuring it counts the particles directly, rather than estimating them from the amount of cholesterol they are carrying.
It is closer to the mechanism, because particle number is what drives deposition. Where the two agree, either works. Its value is in identifying the people for whom they disagree — most often those with raised triglycerides and insulin resistance, whose LDL cholesterol can read normal while particle count is high.
An LDL-like particle with an additional protein attached, which raises cardiovascular risk independently of the rest of your lipid panel. Levels are set largely by genetics and stay fairly stable through life.
Once. Because it is inherited and stable, a single measurement answers the question for good. Most people have never had it done.
Not meaningfully. What a high result changes is how assertively and how early everything modifiable gets addressed — blood pressure, ApoB, metabolic health. It is also worth knowing for your family, since it is inherited.
Routine lipid screening was built around total cholesterol, LDL, HDL and triglycerides, and the major risk calculators are constructed from those. Screening protocols change slowly. Both tests are widely available and neither is expensive; they simply sit outside the standard set.
A fasting morning draw is preferred, mainly so triglycerides and fasting insulin read accurately alongside them.
